- Previous Close
3.340 - Open
3.300 - Bid 3.280 x --
- Ask 3.340 x --
- Day's Range
3.300 - 3.300 - 52 Week Range
2.240 - 5.500 - Volume
1,500 - Avg. Volume
51,743 - Market Cap (intraday)
1.35B - Beta (5Y Monthly) -0.15
- PE Ratio (TTM)
13.20 - EPS (TTM)
0.250 - Earnings Date --
- Forward Dividend & Yield 0.12 (3.64%)
- Ex-Dividend Date Jun 23, 2025
- 1y Target Est
--
Sinohealth Holdings Limited provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally. The company operates through four segments: Smart Retail Cloud, Smart Decision Cloud, Smart Health Management Cloud, and Smart Medical Cloud. It engages in the research and development and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) product; research and development and the operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of innovative medicine; operation of SaaS products; provision of internet information and internet data center services; and engages in foreign-related market research business. The company also offers precision marketing solutions; and consulting and marketing services. It serves various fields, such as pharmaceutical industry, retail pharmacies, and physical examination and hospitals. The company was founded in 2007 and is headquartered in Guangzhou, China.
ir.sinohealth.cn768
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2361.HK
View MorePerformance Overview: 2361.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2361.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2361.HK
View MoreValuation Measures
Market Cap
1.35B
Enterprise Value
828.76M
Trailing P/E
13.44
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.15
Price/Book (mrq)
1.84
Enterprise Value/Revenue
1.89
Enterprise Value/EBITDA
6.79
Financial Highlights
Profitability and Income Statement
Profit Margin
27.41%
Return on Assets (ttm)
6.26%
Return on Equity (ttm)
15.87%
Revenue (ttm)
403.73M
Net Income Avi to Common (ttm)
110.65M
Diluted EPS (ttm)
0.250
Balance Sheet and Cash Flow
Total Cash (mrq)
559.65M
Total Debt/Equity (mrq)
1.66%
Levered Free Cash Flow (ttm)
--